Enveric Biosciences Inc (ENVB) - News Archive

Enveric Biosciences Signs Term Sheets for Out-Licensing Neuroplastogenic Compounds and Unveils Promising Drug Candidates for Mental Health DisordersEnveric Biosciences (NASDAQ: ENVB), a biotechnology company focused on...

In recent years, there has been an increasing focus on the development of novel therapeutics for the treatment of mental health disorders such as depression, anxiety, and addiction. Enveric Biosciences, a biotechnology...

Enveric Biosciences Expands Potential Partnership Opportunities Through Licensing Three Classes of CompoundsEnveric Biosciences, a biotechnology company focused on the development of small-molecule therapeutics for ment...

Enveric Biosciences, a forward-thinking biotechnology company, has made significant strides in the field of cancer treatment through the development of novel neuroplastogenic small-molecule therapeutics. As part of thei...

Enveric Biosciences Unveils Novel Compounds for Mental Health Disorders: A Step Towards Breakthrough Neuroplastogenic Therapeutics Enveric Biosciences, a prominent biotechnology company, has recently unveiled a library...

Enveric Biosciences, a pioneering biotechnology company specializing in the development of novel neuroplastogenic small-molecule therapeutics for mental health disorders, has recently provided an update on the selection...

Enveric Biosciences Announces Successful Exercise of Warrants and New Issuance in Private Placement for $1.8 Million Gross ProceedsCAMBRIDGE, Mass. - Enveric Biosciences (NASDAQ: ENVB), a biotechnology company specializ...

Cambridge, Mass. - Enveric Biosciences (NASDAQ: ENVB), a renowned biotechnology company focused on developing innovative small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders, has...

Enveric Biosciences Achieving Significant Milestones in Preclinical Development of Lead Prodrug Candidate EB-373 for Neurological DisordersCambridge, Mass. - Enveric Biosciences (NASDAQ: ENVB), a renowned biotechnology...

Enveric Biosciences, a leading biotechnology company, has recently made significant strides in the development of innovative therapeutics for the treatment of depression, anxiety, and addiction disorders. By selecting t...

Enveric Biosciences Receives Patent Approval for Groundbreaking Glycosylated Psilocybin Derivatives, Pioneering a New Era in Mental Health TherapeuticsCAMBRIDGE, Mass. - Enveric Biosciences (NASDAQ: ENVB), a leading bio...

Enveric Biosciences, a renowned biotechnology company, has recently achieved a significant milestone in the development of a groundbreaking neuroplastogenic small-molecule therapeutic candidate. The company s lead produ...

Enveric Biosciences, a leading biotechnology company focused on groundbreaking neuroplastogenic small-molecule therapeutics, recently made waves at the Canadian Chemical Engineering Conference (CSChE 2023). The company...

Enveric Biosciences Receives Notice of Allowance from USPTO for Innovative Prodrug of Psilocin, Advancing Breakthrough Therapeutics for Mental Health DisordersEnveric Biosciences (NASDAQ: ENVB), a pioneering biotechnolo...